25 results on '"Quinn MP"'
Search Results
2. Inferior Oblique Palsy After Cosmetic Botox Injection for Glabellar Lines: A Case Report.
- Author
-
Pucchio AA and Quinn MP
- Subjects
- Humans, Female, Trochlear Nerve Diseases chemically induced, Trochlear Nerve Diseases diagnosis, Cosmetic Techniques adverse effects, Oculomotor Muscles drug effects, Injections, Intramuscular adverse effects, Botulinum Toxins, Type A adverse effects, Botulinum Toxins, Type A administration & dosage, Neuromuscular Agents adverse effects, Neuromuscular Agents administration & dosage
- Abstract
Competing Interests: The authors report no conflicts of interest.
- Published
- 2024
- Full Text
- View/download PDF
3. Visual impairment, employment status, and reduction in income: the Canadian Longitudinal Study on Aging.
- Author
-
Iverson E, Sukhai M, Quinn MP, Aubin MJ, and Freeman EE
- Abstract
Objective: To examine the employment status of those with and without visual impairment and eye disease and to examine the association between visual impairment and eye disease and a reduction in income over a 3-year period., Design: Population-based prospective cohort study., Participants: A total of 12,174 nonretired participants aged 45-64 years old in the Canadian Longitudinal Study on Aging., Methods: Visual impairment was defined if binocular presenting or pinhole-corrected monocular visual acuity in the better eye was worse than 20/40 at baseline. Self-reported diagnoses of age-related macular degeneration (AMD) and glaucoma were collected. Employment status (employed, not employed due to sickness or disability, or unemployed) was based on questions on labour force participation. Income reduction was defined as household income <$50,000 per year at follow-up when household income was ≥$50,000 at baseline. Multinomial and logistic regressions were used to adjust for demographic and health variables., Results: Visual impairment using binocular presenting visual acuity (odds ratio [OR] = 2.09; 95% CI, 1.21-3.62) and pinhole-corrected visual acuity (OR = 2.99; 95% CI, 1.54-5.83) were associated with a higher odds of not being employed due to sickness or disability after adjustment. AMD (OR = 1.82; 95% CI, 1.11-3.01) and glaucoma (OR = 2.05; 95% CI, 1.28-3.28) at baseline were both associated with reductions in income over a 3-year period after adjustment., Conclusion: Individuals with visual impairment experienced lower employment, and those with AMD or glaucoma were more likely to have their incomes decline over 3 years. Policies to improve workplace participation by those with vision loss are needed., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
4. Evolution of first-line glaucoma therapy, 2007-2018: a population-based analysis.
- Author
-
Doliszny K, Quinn MP, El-Defrawy SR, Gill SS, Whitehead M, Johnson D, and Campbell RJ
- Subjects
- Humans, Retrospective Studies, Adrenergic beta-Antagonists, Delivery of Health Care, Glaucoma drug therapy, Glaucoma epidemiology, Trabeculectomy
- Abstract
Objective: To evaluate the long-term evolution of first-line glaucoma therapy (FLGT) initiated by ophthalmologists and optometrists., Design: Retrospective population-based study using validated provincial health care databases., Participants: 194,759 Ontario residents, 66 years of age or older, who received FLGT between 2007 and 2018., Methods: A total of 194,759 individuals from 12 annual cohorts were enrolled, and rates of first-line medical treatment (prostaglandin analogue [PGA], beta-blocker, alpha-2-agonist, and carbonic anhydrase inhibitor) and laser trabeculoplasty (LT) were calculated. Provider (ophthalmologist or optometrist) rates also were assessed., Results: Across the entire study period, of the 194,759 enrolled individuals who received FLGT, 60.2% initially received medical treatment and 39.8% underwent LT. Approximately 94.6% were treated by ophthalmologists. PGA therapy was the most common therapy prior to 2010, whereupon LT became the most common FLGT. By 2015, LT exceeded the total of all medications as FLGT. The annual rate of initial medication prescriptions by optometrists rose to 101.4 per 100,000 population between 2011 and 2018. In 2018, PGA and non-PGA prescription rates by ophthalmologists were 2.6 and 5.0 times higher, respectively, than prescription rates by optometrists., Conclusion: LT therapy has become the most common FLGT for Ontario residents 66 years of age or older. PGAs remain the most frequently prescribed glaucoma medication. While ophthalmologists continue to provide the majority of FLGT, optometrists now provide a small but growing fraction of FLGT following the introduction of glaucoma medication prescribing privileges., Competing Interests: Footnotes and Disclosure None of the authors has any conflicts of interest to disclose. This study was supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). This study was based on data compiled by ICES. Parts of this material are based on data and information compiled and provided by the Ontario MOH and MLTC, Ontario Health Insurance Plan (OHIP) database, Ontario Drug Benefit (ODB) database and IQVIA Solutions Canada, Inc., Ontario Registered Persons database, and ICES Physician database. The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred. Robert J. Campbell is supported by the David Barsky Chair in Ophthalmology and Visual Sciences, Queen's University, Kingston, Ontario. Data access and responsibility: ICES is an independent, nonprofit research institute funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). As a prescribed entity under Ontario's privacy legislation, ICES is authorized to collect and use health care data for the purposes of health system analysis, evaluation, and decision support. Secure access to these data is governed by policies and procedures that are approved by the Information and Privacy Commissioner of Ontario. The data sets from this study are held securely in coded form at ICES. These data sets were linked using unique encoded identifiers and analyzed at ICES. Robert J. Campbell had full access to the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Author contributions: Robert J. Campbell was responsible for conception and design of the study, data acquisition and interpretation, manuscript drafting and revision, approval of the final version, and overall study accountability. Katharine Doliszny was responsible for study design, data acquisition and interpretation, manuscript drafting and revision, approval of the final version, and overall study accountability. Marlo Whitehead was responsible for study design, data acquisition and interpretation, manuscript revision, approval of the final version, and overall study accountability. Matthew P. Quinn, Sherif R. El-Defrawy, Sudeep S. Gill, and Davin Johnson were responsible for interpretation of the results, revision and approval of the manuscript, and overall study accountability., (Copyright © 2022 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. Thrombophlebitis-Mediated Polycranial Neuropathy Secondary to Herpes Zoster Ophthalmicus.
- Author
-
Lampen SIR, Quinn MP, Pike D, Rullo J, and Ten Hove MW
- Subjects
- Humans, Antiviral Agents therapeutic use, Herpes Zoster Ophthalmicus complications, Herpes Zoster Ophthalmicus diagnosis, Herpes Zoster Ophthalmicus drug therapy, Thrombophlebitis complications, Thrombophlebitis drug therapy
- Abstract
Competing Interests: The authors report no conflicts of interest.
- Published
- 2023
- Full Text
- View/download PDF
6. Evaluating Measurement Properties of Patient-Reported Outcome Measures in Glaucoma: A Systematic Review.
- Author
-
Vinokurtseva A, Quinn MP, Wai M, Leung V, Malvankar-Mehta M, and Hutnik CML
- Subjects
- Adult, Humans, Reproducibility of Results, Patient Reported Outcome Measures, Surveys and Questionnaires, Quality of Life, Glaucoma diagnosis
- Abstract
Topic: The purpose of the current study was to systematically identify and evaluate existing patient-reported outcome measures (PROMs) for clinical glaucoma practice., Clinical Relevance: Understanding and incorporating patient preferences into decision-making is now recognized as critical for optimal resource allocation, especially in technologically advancing areas, such as minimally invasive surgeries. Patient-reported outcome measures are instruments designed to evaluate the health outcomes that are most important to patients. Despite their recognized importance, especially in the era of patient-centered care, their routine use in clinical settings remains low., Methods: A systematic literature search was conducted in 6 databases (EMBASE, MEDLINE, PsycINFO, Scopus, BIOSIS, and Web of Science) from the date of inception. Studies were included in the qualitative review if they reported measurement properties of PROMs in adult patients with glaucoma. COnsensus-based Standards for the selection of health Measurement INstruments guidelines were used to assess the included PROMs. The study protocol is registered with PROSPERO (registration number: CRD42020176064)., Results: The literature search yielded 2661 records. After deduplication, 1259 studies entered level 1 screening, and based on title and abstract review, 164 records proceeded to full-text screening. In 48 included studies, 70 instrument reports discuss 43 distinct instruments in 3 major categories: glaucoma-specific, vision-specific, and general health-related quality of life. Most used measures were glaucoma-specific (Glaucoma Quality of Life [GQL] and Glaucoma Symptom Scale [GSS]) and vision-specific (National Eye Institute Visual Function Questionnaire [NEI VFQ-25]). All 3 have sufficient validity (especially construct), with GQL and GSS having sufficient internal consistency, cross-cultural validity, and reliability, with reports suggesting high methodological quality., Conclusion: The GQL, GSS, and NEI VFQ-25 are the 3 most used questionnaires in a research setting, having considerable validation in a patient population with glaucoma. Limited reports on interpretability, responsiveness, and feasibility in all 43 identified instruments make identifying a single optimal questionnaire for clinical use challenging and highlight the need for further studies., Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article., (Copyright © 2023 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
7. Association of topical glaucoma medications with lacrimal drainage obstruction and eyelid malposition.
- Author
-
Quinn MP, Kratky V, Whitehead M, Gill SS, McIsaac MA, and Campbell RJ
- Subjects
- Humans, Retrospective Studies, Eyelids, Entropion diagnosis, Entropion etiology, Entropion surgery, Trichiasis complications, Ectropion etiology, Ectropion surgery, Glaucoma complications, Blepharoptosis
- Abstract
Background/objectives: Adverse effects of topical glaucoma medications (TGMs) may include development of ocular adnexal disorders. We undertook a study to determine the effect of TGMs on the risk of developing lacrimal drainage obstruction (LDO) and eyelid malposition., Subjects/methods: All patients 66 years of age and older in Ontario, Canada initiating TGM and all patients diagnosed with glaucoma/suspected glaucoma but not receiving TGM from 2002 to 2018 were eligible for inclusion in this retrospective cohort study. Using validated healthcare administrative databases, cohorts were identified with TGM and no TGM patients matched 1:2 on sex and birth year. The effect of TGM treatment on risk of surgery for LDO and lid malpositions was estimated using Kaplan-Meier and Cox proportional hazards models., Results: Cohorts included 122,582 patients in the TGM cohort and 232,336 patients in the no TGM cohort. Among the TGM cohort there was decreased event-free survival for entropion (log-rank P < 0.001), trichiasis (P < 0.001), and LDO (P = 0.006), and increased ectropion-free survival (P = 0.007). No difference in ptosis-free survival was detected (P = 0.78). For the TGM cohort there were increased hazards for entropion (hazard ratio [HR] 1.24, 95% confidence interval [CI] 1.12-1.37; P < 0.001), trichiasis (HR 1.74, 95% CI 1.57-1.94; P < 0.001), and LDO (at 15 years: HR 2.39, 95% CI 1.49-3.85; P = 0.004), and a decreased hazard for ectropion (HR 0.89, 95% CI 0.81-0.97; P = 0.008). No association between TGM treatment and ptosis hazard was detected (HR 0.99, 95% CI 0.89-1.09; P = 0.78)., Conclusions: TGMs are associated with an increased risk of undergoing surgery for LDO, entropion, and trichiasis., (© 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.)
- Published
- 2023
- Full Text
- View/download PDF
8. Bilateral Peripheral Ulcerative Keratitis Associated with Dupilumab.
- Author
-
Far PM, Quinn MP, and Johnson D
- Subjects
- Antibodies, Monoclonal, Humanized adverse effects, Humans, Corneal Ulcer chemically induced, Corneal Ulcer diagnosis, Corneal Ulcer drug therapy
- Published
- 2022
- Full Text
- View/download PDF
9. Predictors of Initial Glaucoma Therapy with Laser Trabeculoplasty versus Medication: A Population-Based Study.
- Author
-
Quinn MP, Johnson D, Whitehead M, Gill SS, and Campbell RJ
- Subjects
- Female, Humans, Lasers, Male, Ontario epidemiology, Glaucoma drug therapy, Laser Therapy, Trabeculectomy
- Abstract
Purpose: To investigate patient-level factors associated with first-line glaucoma therapy with laser trabeculoplasty (LT) versus topical medication., Design: Population-based study., Participants: All patients 66 years of age and older in Ontario, Canada, receiving first-ever therapy for glaucoma with either LT or topical medication between April 1, 2007, and March 31, 2019., Methods: Linked health care databases were used to identify patients receiving first-line glaucoma therapy and to ascertain patient-level factors potentially associated with receipt of LT versus medication. Multivariate logistic regression analyses were undertaken., Main Outcome Measures: Factors associated with receiving LT versus medications were evaluated using adjusted odds ratios (ORs) for age, gender, previous cataract surgery, previous corneal transplantation, previous retina surgery, level of systemic comorbidity, socioeconomic status (SES), and rural versus urban residence., Results: In total, 194 759 patients were included. Older patients were less likely to be treated with LT versus medication (≥81 years of age vs. 66-70 years of age: OR, 0.49; 95% confidence interval [CI], 0.48-0.50), whereas women were more likely than men to receive LT (OR, 1.42; 95% CI, 1.39-1.45). Previous ocular surgeries were associated with decreased probability of treatment with LT, including cataract surgery (OR, 0.31; 95% CI, 0.30-0.32), corneal transplantation (OR, 0.39; 95% CI, 0.31-0.49), and retina surgery (OR, 0.46; 95% CI, 0.41-0.51). Patients with high comorbidity were less likely to receive LT (highest vs. lowest level of comorbidity: OR, 0.94; 95% CI, 0.91-0.97). Laser trabeculoplasty use was less likely among patients at higher levels of SES (highest vs. lowest level: OR, 0.86; 95% CI, 0.84-0.89) and from a rural residence (versus urban: OR, 0.92; 95% CI, 0.90-0.95). Increasing utilization of LT over time was noted (for each additional calendar year: OR, 1.05 per year; 95% CI, 1.05-1.05 per year)., Conclusions: Our results identified patient characteristics associated with use of LT as primary therapy for glaucoma, including factors related to patient demographics, ocular history, and comorbidity. Many of these associations are unexpected based on efficacy data or evidence-based guidelines. These results are topical considering growing evidence supporting use of first-line LT., (Copyright © 2020 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
10. Distribution and Predictors of Initial Glaucoma Care Among Ophthalmologists and Optometrists: A Population-based Study.
- Author
-
Quinn MP, Johnson D, Whitehead M, Gill SS, and Campbell RJ
- Subjects
- Humans, Intraocular Pressure, Glaucoma diagnosis, Glaucoma epidemiology, Glaucoma therapy, Ophthalmologists, Ophthalmology, Optometrists, Optometry
- Abstract
Purpose: To evaluate evolution in the distribution of new glaucoma patients between ophthalmologists and optometrists, and to examine factors predicting provider type, in the context of expansion in the scope of optometry practice., Patients and Methods: A population-based study was undertaken using validated datasets in Ontario, Canada from 2007 to 2018, encompassing time before and after optometry practice scope expansion in 2011. All patients aged 66 and older receiving a glaucoma suspect diagnosis or first-line therapy for glaucoma from ophthalmologists or optometrists were enrolled. Predictors of provider type were evaluated using logistic regression., Results: From 2007 to 2018, 401,560 patients received initial glaucoma care, including 303,440 by ophthalmologists and 98,120 by optometrists. Population rates of glaucoma suspect diagnosis increased for both providers over the study period. The rate of therapy initiation increased annually among optometrists after 2011, while the rate remained stable over that period among ophthalmologists. By 2018, 88% of patients initiating therapy and 59% of patients first diagnosed as a glaucoma suspect received that care from ophthalmologists. In the final study year, therapy initiations per provider were lower among optometrists (median: 2/provider; interquartile range: 1 to 3) than among ophthalmologists (median: 26.5/provider, interquartile range: 10 to 53). Patients were more likely to receive care from an ophthalmologist than an optometrist if they were older, had higher ocular or systemic comorbidity, or lived in urban settings., Conclusions: Optometrists have a large and growing role in diagnosing glaucoma suspects; however, despite scope expansion, optometrists play a much smaller role in initiating glaucoma therapy., Competing Interests: Disclosure: The authors declare no conflict of interest., (Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
11. Early ocular findings in Cohen syndrome: case report and Canadian survey study.
- Author
-
Quinn MP, MacKeen LD, Vincent A, and Strube YNJ
- Subjects
- Canada, Developmental Disabilities, Fingers abnormalities, Humans, Muscle Hypotonia, Myopia, Obesity, Retinal Degeneration, Intellectual Disability, Microcephaly
- Published
- 2021
- Full Text
- View/download PDF
12. Putaminal Diffusion Restriction in a Case of Methanol Toxicity with Clinical Recovery.
- Author
-
Quinn MP, Bursztyn LL, and Sharma M
- Abstract
A 32-year-old male presented to the emergency department for confusion, dyspnea, and a "white out" of his central vision over the preceding 24 hours. The patient had recently consumed a bottle of alcohol purchased overseas. Bloodwork revealed a severe metabolic acidosis (pH 6.90) and a critically high methanol level of 28.9 mmol/l. Shortly after presentation, the patient went into respiratory failure and became comatose. He was intubated and admitted to the ICU.
- Published
- 2020
- Full Text
- View/download PDF
13. Increased deep gray matter iron is present in clinically isolated syndromes.
- Author
-
Quinn MP, Gati JS, Klassen ML, Lee DH, Kremenchutzky M, and Menon RS
- Abstract
Objective: Abnormal iron accumulation in MS has been known for decades, however it remains to be established whether iron reflects a cause or epiphenomenon of pathology. The objective of the present study is to determine if iron is increased in the brains of patients with clinically isolated syndromes (CIS) suggestive of early MS., Methods: Twenty-two patients with a CIS and 16 age- and sex-matched controls underwent 3T MRI studies. Differences in R2*, a metric of iron concentration, were assessed for all voxels throughout the brain. Similar clusters of significant differences were grouped, wherein mean R2* was regressed against a number of parameters, including extended disability status scale (EDSS), age, disease duration, and internal jugular vein (IJV) cross-sectional area (CSA), as measured from magnetic resonance time-of-flight venograms., Results: Patients had significantly increased R2* in globus pallidus, thalamus, right pulvinar, and cortical areas. Thalamic R2* correlated positively with EDSS. Decreased white matter R2* was detected at various positions in the patient group average. No correlations were found between any changes in R2* and IJV CSA., Interpretation: Iron is increased in CIS in deep gray matter, suggesting this iron accumulation, well-known in definite MS, occurs early in the disease course. Increases in thalamic iron are associated with worsened clinical status. Decreased white matter R2* may be interpreted as diffuse damage to normal appearing white matter, not often reported in CIS. Observations do not support a role for venous abnormalities in either iron accumulation or white matter damage., (Copyright © 2013 Elsevier B.V. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
14. Comparison of multiecho postprocessing schemes for SWI with use of linear and nonlinear mask functions.
- Author
-
Quinn MP, Gati JS, Klassen LM, Lin AW, Bird JR, Leung SE, and Menon RS
- Subjects
- Humans, Image Enhancement methods, Linear Models, Nonlinear Dynamics, Reproducibility of Results, Sensitivity and Specificity, Algorithms, Cerebral Veins anatomy & histology, Echo-Planar Imaging methods, Image Interpretation, Computer-Assisted methods, Magnetic Resonance Angiography methods
- Abstract
Background and Purpose: SWI is an MR technique conventionally implemented with single-echo gradient-echo data. The purpose of this study was to compare single-echo SWI processing and 2 multiecho SWI processing schemes: postaverage, where an SWI image is created for each echo and then averaged to create a single volume; and frequency-based, where a SWI image is generated from an average frequency image. Linear and nonlinear mask functions were investigated for all 3 processing schemes., Materials and Methods: Comprehensive optimizations were performed. Single and multigradient-echo data were acquired at 3T in 10 volunteers. Contrast-to-noise ratio was measured in various structures. Visibilities of the same structures were ranked in different SWI images by trained raters., Results: When image evaluation was based on measurements of contrast-to-noise ratio, the nonlinear mask and frequency-based scheme were superior. However, when image evaluation was based on ranks of qualitative visibility, the linear mask and postaverage scheme were superior. Although the nonlinear mask and frequency-based scheme allow increased contrast of paramagnetic perturbers such as the globus pallidus, periventricular veins, red nucleus, and subthalamic nucleus, they do not necessarily increase the information content of the image; rather, they result in a harsh contrast that is visually unpleasing to radiologists and wherein more subtle structure is relatively less apparent., Conclusions: Linearly masked postaverage SWI is the recommended implementation of multiecho SWI for radiologic use; however, nonlinearly masked frequency-based SWI may have use in computer-based segmentation or registration.
- Published
- 2014
- Full Text
- View/download PDF
15. Venocentric Lesions: An MRI Marker of MS?
- Author
-
Quinn MP, Kremenchutzky M, and Menon RS
- Abstract
From the earliest descriptions of multiple sclerosis (MS), the venocentric characteristic of plaques was noted. Recently, numerous magnetic resonance imaging (MRI) studies have proposed this finding as a prospective biomarker for MS, which might aid in differentiating MS from other diseases with similar MRI findings. High-field MRI studies have shown that penetrating veins can be detected in most MS lesions using T2(∗) weighted or susceptibility-weighted imaging. Future studies must address the feasibility of imaging such veins in a clinically practical context. The specificity of this biomarker has been studied only in a limited capacity. Results in microangiopathic lesions are conflicting, whereas asymptomatic white matter hyperintensities as well as lesions of neuromyelitis optica are less frequently venocentric compared to MS plaques. Prospective studies have shown that the presence of venocentric lesions at an early clinical presentation is highly predictive of future MS diagnosis. This is very promising, but work remains to be done to confirm or exclude lesions of common MS mimics, such as acute disseminate encephalomyelitis, as venocentric. A number of technical challenges must be addressed before the introduction of this technique as a complementary tool in current diagnostic procedures.
- Published
- 2013
- Full Text
- View/download PDF
16. Patterns of hospitalisation before and following initiation of haemodialysis: a 5 year single centre study.
- Author
-
Quinn MP, Cardwell CR, Rainey A, McNamee PT, Kee F, Maxwell AP, Fogarty DG, and Courtney AE
- Subjects
- Adult, Aged, Aged, 80 and over, Bed Occupancy statistics & numerical data, Comorbidity, Female, Health Services Research methods, Humans, Length of Stay statistics & numerical data, Male, Middle Aged, Northern Ireland, Hospitalization statistics & numerical data, Kidney Failure, Chronic therapy, Renal Dialysis
- Abstract
BACKGROUND The utilisation of healthcare resources by prevalent haemodialysis patients has been robustly evaluated with regard to the provision of outpatient haemodialysis; however, the impact of hospitalisation among such patients is poorly defined. Minimal information is available in the UK to estimate the health and economic burden associated with the inpatient management of prevalent haemodialysis patients. The aim of this study was to assess the pattern of hospitalisation among a cohort of haemodialysis patients, before and following their initiation of haemodialysis. In addition the study sought to assess the impact of their admissions on bed occupancy in a large tertiary referral hospital in a single region in the UK. METHODS All admission episodes were reviewed and those receiving dialysis with the Belfast City Hospital Programme were identified over a 5 year period from January 2001 to December 2005. This tertiary referral centre provides dialysis services for a population of approximately 700 000 and additional specialist renal services for the remainder of Northern Ireland. The frequency and duration of hospitalisation, and contribution to bed day occupancy of haemodialysis patients, was determined and compared to other common conditions which are known to be associated with high bed occupancy. In addition, the pattern and timing of admissions in dialysis patients in relation to their dialysis initiation date was assessed. RESULTS Over the 5 year study period, 798 haemodialysis patients were admitted a total of 2882 times. These accounted for 2.5% of all admissions episodes; the median number of admissions for these patients was 3 (2-5) which compared with 1 (1-2) for non-dialysis patients. The majority of first hospitalisations (54%) were within 100 days before or after commencement of maintenance dialysis therapy. In all clinical specialties the median length of stay for haemodialysis patients was significantly longer than for patients not on haemodialysis (p=0.004). In multivariate analysis with adjustment for age, gender, and other clinically relevant diagnostic codes, maintenance haemodialysis patients stayed on average 3.75 times longer than other patient groups (ratio of geometric means 3.75, IQR 3.46-4.06). CONCLUSIONS Maintenance haemodialysis therapy is an important risk factor for prolonged hospitalisation regardless of the primary reason for admission. Such patients require admission more frequently than the general hospital population, particularly within 100 days before and after initiation of their first dialysis treatment.
- Published
- 2011
- Full Text
- View/download PDF
17. The finding of reduced estimated glomerular filtration rate is associated with increased mortality in a large UK population.
- Author
-
Quinn MP, Cardwell CR, Kee F, Maxwell AP, Savage G, McCarron P, and Fogarty DG
- Subjects
- Adult, Aged, Cardiovascular Diseases physiopathology, Cause of Death, Cohort Studies, Female, Glomerular Filtration Rate, Humans, Kidney Function Tests, Male, Middle Aged, Northern Ireland, Renal Dialysis, Retrospective Studies, Risk Factors, Survival Rate, United States, Young Adult, Cardiovascular Diseases mortality, Creatinine blood, Kidney Failure, Chronic mortality
- Abstract
Background: CKD as defined by KDIGO/KDOQI has been shown to affect ~ 8.5% of the UK population. The prevalence of CKD in the UK is similar to that in the USA, yet incident dialysis rates are dramatically different. This retrospective cohort study investigates the association between reduced kidney function and mortality in a large UK population., Methods: All serum creatinine results covering Northern Ireland's 1.7 million population were collected between 1 January 2001 and 31 December 2002. Estimated glomerular filtration rates (eGFR) were calculated for all serum creatinine measurements using four-variable MDRD equation (IDMS aligned). Patients were followed up for both all-cause and cardiovascular mortality data until the end of December 2006. Patients on renal replacement therapy were excluded. Subgroup analysis in the 75,345 subjects enrolled within a parallel primary care study permitted additional survival analysis with adjustment for traditional cardiovascular risk factors., Results: A total of 1,967,827 serum creatinine results from 533,798 patients were collected. During the period of follow-up, 59,980 deaths occurred. In multivariate survival analysis, using eGFR as a time-varying covariate, a graded association between CKD (defined by eGFR) and all-cause mortality was identified. Compared with participants with an eGFR of > 60 mL/min/1.73 m(2), the adjusted hazard ratios (and 95% confidence intervals) for participants with an eGFR of 45-59 mL/min/1.73 m(2) was 1.02 (0.99-1.04), an eGFR of 30-44 mL/min/1.73 m(2) was 1.44 (1.40-1.47), an eGFR of 15-29 mL/min/1.73 m(2) was 2.12 (2.05-2.20) and an eGFR of < 15 mL/min/1.73 m(2) was 3.46 (3.24-3.70). Significantly, increased all-cause mortality was associated with an eGFR < 45 mL/min/1.73 m(2) following adjustment for age and gender. The association between cardiovascular mortality and reduced renal function continued to be significant for participants with an eGFR of 45-65 mL/min/1.73 m(2). Subgroup analysis in 75,345 individuals with more detailed clinical information available confirmed this association following adjustment for traditional cardiovascular risk factors in addition to age and gender., Conclusions: This study demonstrates a graded association between reduced renal function as represented by eGFR and mortality in a UK population. The all-cause and cardiovascular mortality risk increases sharply when estimated GFR falls < 45 mL/min/1.73 m(2). The association between an eGFR measured between 45 and 65 mL/min/1.73 m(2) and cardiovascular mortality persists in this cohort and highlights the ongoing uncertainty in accurately categorizing renal dysfunction.
- Published
- 2011
- Full Text
- View/download PDF
18. Titanium(IV) halide mediated coupling of alkoxides and alkynes: an efficient and stereoselective route to trisubstituted (E)-alkenyl halides.
- Author
-
Yao ML, Quick TR, Wu Z, Quinn MP, and Kabalka GW
- Abstract
Alkoxide C-O bond cleavage occurs readily at room temperature in the presence of titanium(IV) halide. Capture of the resultant carbocation by alkynes provides an efficient route to trisubstituted (E)-alkenyl halides with high stereoselectivity.
- Published
- 2009
- Full Text
- View/download PDF
19. The impact of admissions for the management of end-stage renal disease on hospital bed occupancy.
- Author
-
Quinn MP, Cardwell CR, Rainey A, McNamee PT, Kee F, Maxwell AP, Fogarty DG, and Courtney AE
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, United Kingdom epidemiology, Bed Occupancy statistics & numerical data, Kidney Failure, Chronic epidemiology, Kidney Failure, Chronic therapy, Patient Admission statistics & numerical data, Utilization Review
- Abstract
Background: End-stage renal disease (ESRD) is increasingly prevalent but the inpatient costs associated with this condition are poorly defined due to limitations with data extraction and failure to differentiate between hospitalisation for renal and non-renal disease reasons. The impact of admissions primarily for the management of ESRD on hospital bed utilisation was assessed over a 5-year period in a large teaching hospital., Methods: All admission episodes were reviewed and the ESRD group was identified by a primary International Classification of Diseases code for ESRD or a non-specific primary renal failure code with a secondary code for ESRD. The frequency and duration of hospitalisation and contribution to bed day occupancy of this group with ESRD was determined., Results: There were 70,808 patients responsible for a total of 116,915 admissions and 919,212 bed days over the study period. Of these, 988 (1.4%) patients were admitted for the management of ESRD, accounting for 2,387 (2.0%) of admissions and utilisation of 23,011 (2.5%) bed days. After adjustment for age and gender, those admitted for ESRD management were significantly more likely to have a prolonged admission exceeding 30 days (odds ratio 1.46, 95% confidence interval 1.23-1.72, p < 0.001). When the admission was an emergency rather than an elective event, the patient was 4.6 times more likely to be hospitalised for over 30 days., Conclusions: Persons admitted for ESRD management are hospitalised more frequently and for longer than the overall inpatient population, occupying a substantial number of bed days., ((c) 2009 S. Karger AG, Basel.)
- Published
- 2009
- Full Text
- View/download PDF
20. The practical implications of using standardized estimation equations in calculating the prevalence of chronic kidney disease.
- Author
-
Quinn MP, Rainey A, Cairns KJ, Marshall AH, Savage G, Kee F, Peter Maxwell A, Reaney E, and Fogarty DG
- Subjects
- Adult, Aged, Aged, 80 and over, Chronic Disease, Creatinine blood, Female, Humans, Kidney Diseases blood, Kidney Diseases physiopathology, Male, Mathematics, Middle Aged, Prevalence, Glomerular Filtration Rate, Kidney Diseases epidemiology
- Abstract
Background: Kidney Disease Outcomes Quality Initiative (KDOQI) chronic kidney disease (CKD) guidelines have focused on the utility of using the modified four-variable MDRD equation (now traceable by isotope dilution mass spectrometry IDMS) in calculating estimated glomerular filtration rates (eGFRs). This study assesses the practical implications of eGFR correction equations on the range of creatinine assays currently used in the UK and further investigates the effect of these equations on the calculated prevalence of CKD in one UK region, Methods: Using simulation, a range of creatinine data (30-300 micromol/l) was generated for male and female patients aged 20-100 years. The maximum differences between the IDMS and MDRD equations for all 14 UK laboratory techniques for serum creatinine measurement were explored with an average of individual eGFRs calculated according to MDRD and IDMS < 60 ml/min/1.73 m(2) and 30 ml/min/1.73 m(2). Similar procedures were applied to 712,540 samples from patients > or = 18 years (reflecting the five methods for serum creatinine measurement utilized in Northern Ireland) to explore, graphically, maximum differences in assays. CKD prevalence using both estimation equations was compared using an existing cohort of observed data., Results: Simulated data indicates that the majority of laboratories in the UK have small differences between the IDMS and MDRD methods of eGFR measurement for stages 4 and 5 CKD (where the averaged maximum difference for all laboratory methods was 1.27 ml/min/1.73 m(2) for females and 1.59 ml/min/1.73 m(2) for males). MDRD deviated furthest from the IDMS results for the Endpoint Jaffe method: the maximum difference of 9.93 ml/min/1.73 m(2) for females and 5.42 ml/min/1.73 m(2) for males occurred at extreme ages and in those with eGFR > 30 ml/min/1.73 m(2). Observed data for 93,870 patients yielded a first MDRD eGFR < 60 ml/min/1.73 m(2) in 2001. 66,429 (71%) had a second test > 3 months later of which 47,093 (71%) continued to have an eGFR < 60 ml/min/1.73 m(2). Estimated crude prevalence was 3.97% for laboratory detected CKD in adults using the MDRD equation which fell to 3.69% when applying the IDMS equation. Over 95% of this difference in prevalence was explained by older females with stage 3 CKD (eGFR 30-59 ml/min/1.73 m(2)) close to the stage 2 CKD (eGFR 60-90 ml/min/1.73 m(2)) interface., Conclusions: Improved accuracy of eGFR is obtainable by using IDMS correction especially in the earlier stages of CKD 1-3. Our data indicates that this improved accuracy could lead to reduced prevalence estimates and potentially a decreased likelihood of onward referral to nephrology services particularly in older females.
- Published
- 2008
- Full Text
- View/download PDF
21. Breathless and dizzy!--disseminated Nocardia farcinica complicating renal transplantation.
- Author
-
Quinn MP, Courtney AE, McCarron MO, McCluskey M, and Hedderwick S
- Subjects
- Adult, Brain pathology, Humans, Kidney Failure, Chronic surgery, Magnetic Resonance Imaging, Male, Dyspnea microbiology, Kidney Transplantation adverse effects, Nocardia Infections diagnosis, Postoperative Complications microbiology
- Published
- 2007
- Full Text
- View/download PDF
22. Influence of prolonged hospitalization on overall bed occupancy: a five-year single-centre study.
- Author
-
Quinn MP, Courtney AE, Fogarty DG, O'reilly D, Cardwell C, and McNamee PT
- Subjects
- Aged, Aged, 80 and over, Epidemiologic Methods, Female, Hospital Bed Capacity, 500 and over statistics & numerical data, Hospitals, Teaching, Humans, Male, Middle Aged, Northern Ireland, Bed Occupancy, Length of Stay
- Abstract
Background: Effective bed use is crucial to an efficient NHS. Current targets suggest a decrease in mean occupancy as the most appropriate method of improving overall efficiency. The elderly and those suffering from complex medical problems are thought to account for a high proportion of overall bed occupancy., Aim: To assess the effect of prolonged hospital stay (>100 days) on overall bed occupancy in a modern teaching hospital., Design: Retrospective analysis., Methods: Analysis of all admission episodes (n = 117,178) over a five-year period in a large teaching hospital in a single UK region, serving a population of approximately 200,000. A logistic regression multi-factorial model was used to assess the effect of demographic and diagnostic variables on duration of stay., Results: A prolonged stay (>100 days) was seen in 648 admission episodes (0.6%). These accounted for 11% of the overall bed occupancy over the 5-year period. Excluding all prolonged admission episodes from our analysis made no difference to the overall median length of stay., Discussion: Prolonged hospitalizations have a significant impact on bed occupancy. Targeting these very long (>100 days) hospital stays may better improve overall efficiency, compared to targeting mean or median length of stay.
- Published
- 2007
- Full Text
- View/download PDF
23. Cardiac tamponade ... a wire too far?
- Author
-
Quinn MP, Maxwell AP, Brown JH, and Finn M
- Subjects
- Cardiac Tamponade diagnostic imaging, Catheterization, Central Venous instrumentation, Humans, Jugular Veins, Male, Middle Aged, Pulmonary Edema complications, Pulmonary Edema therapy, Renal Insufficiency complications, Renal Insufficiency therapy, Tomography, X-Ray Computed, Cardiac Tamponade etiology, Catheterization, Central Venous adverse effects, Catheters, Indwelling adverse effects, Pericardium injuries
- Published
- 2006
- Full Text
- View/download PDF
24. Prospective evaluation of platelet B2 bradykinin and thrombopoietin receptor levels from preeclamptic compared to non-preeclamptic pregnancy patients.
- Author
-
Carroll RC, Owers RL, Elder RF, Hennessey MD, Patteson SK, Snider CC, Hammer NL, Quinn MP, and Muenchen RA
- Subjects
- Adult, Analysis of Variance, Blood Platelets chemistry, Blotting, Western, Cell Separation, Female, Humans, Pre-Eclampsia blood, Pre-Eclampsia diagnosis, Pregnancy, Prospective Studies, Receptors, Thrombopoietin, Reference Values, Blood Platelets metabolism, Pre-Eclampsia metabolism, Proto-Oncogene Proteins metabolism, Receptor, Bradykinin B2 metabolism, Receptors, Cytokine metabolism
- Abstract
Our recent study determined a difference between preeclamptic and non-preeclamptic patients in platelet potentiation by thrombopoietin (TPO) of reactivity to collagen. The main conclusion was that non-preeclamptic, but not preeclamptic, pregnancy patients' platelets showed significant TPO potentiation at first and third trimesters. Since TPO or B2 Bradykinin platelet receptor levels might influence TPO potentiation, we obtained platelet samples from 187 first trimester pregnant patients prospectively followed through pregnancy. Patients were additionally sampled at third trimester, delivery, and 4 to 6 weeks postpartum. A total of 43 patients, including 11 diagnosed as preeclamptic at third trimester, were sampled at least three different times. We used Western blotting normalized with glyceraldehyde 3 phosphate dehydrogenase as a loading and staining control. There were no significant differences in relative receptor levels between groups or sampling times using repeated measures ANOVA with the mixed model allowing for missing samples. While the mechanism for differences in thrombopoietin potentiation of platelet activation by collagen remains unknown, it may be a first trimester indicator of developing preeclampsia.
- Published
- 2006
- Full Text
- View/download PDF
25. From hard copy to computer integration: developing clinical indicators for quality improvement.
- Author
-
Quinn MP, Freeman J, and Humble CG
- Subjects
- Data Collection, Forms and Records Control, Health Personnel education, Hospital Information Systems, Hospitals, Veterans organization & administration, Manuals as Topic, Total Quality Management standards, United States, User-Computer Interface, Computer User Training, Hospitals, Veterans standards, Software, Total Quality Management classification
- Abstract
The Clinical Indicator Workbook is a computerized tool that allows users to develop measures of healthcare quality. The electronic workbook, which includes selected clinical indicators to measure various aspects of patient care and teaching examples, was developed by using a major word processing package and uses a point-and-click feature. Its distribution and installation are managed by a program that enables users to select one of three options: (a) installation of the required files and indicator documents, (b) duplication of material on two diskettes for future distribution within the user's facility, and (c) on-line help. Once the workbook is installed, users are able to copy and customize the indicators for use with interdisciplinary teams in clinical settings. A survey of initial users, who are, for the most part, quality managers in the Veterans Affairs system, indicated that they are satisfied with this tool overall.
- Published
- 1997
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.